Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
주식 순위 #27074
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
주가
$2.04
마지막 동기화: 2025-12-09
시가총액
$35.38M
변동 (1일)
0.00%
변동 (1년)
-2.39%
국가
IE
거래 Mural Oncology plc (MURA)

카테고리

Mural Oncology plc (MURA)의 주가 이력
최고 종가: $2.04 (2025-12-01 기준)

최저 종가: $3.85 (2023-11-01 기준)
Mural Oncology plc의 주가 이력 (2023 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 1.79%
2025 -42.95%
2024 -13.07%
2023 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$756.93 6.35%
CH